Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Dec-2025 03:11 ET (22-Dec-2025 08:11 GMT/UTC)
Mass General Brigham researchers hope findings can inform public health messaging around vaping cessation moving forward
New research taking place at the University of Plymouth's Brain Tumour Research Centre of Excellence, and supported by the Children’s Tumor Foundation, will trial combinations of drugs to try and find the first effective non-surgical treatments for patients with neurofibromatosis type 2 (NF2)
Researchers at Yale University School of Medicine have identified a way to suppress the daily fluctuations in the activity of key immune cells known as neutrophils. The study, to be published December 12 in the Journal of Experimental Medicine (JEM), suggests that inhibiting these fluctuations could prevent neutrophils from causing excessive tissue damage during daylight hours, a phenomenon that may underlie the fact that heart attacks in the early morning are more damaging than heart attacks suffered at night.